Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries
Authors:
- Norma MaddenNMNorma Madden
- Amare W. TadesseATAmare W. Tadesse
- Chung Lam LeungCLChung Lam Leung
- Bianca Gonçalves TascaBTBianca Gonçalves Tasca
- Jason AlacapaJAJason Alacapa
- Natasha DeyanovaNDNatasha Deyanova
- Nontobeko NdlovuNNNontobeko Ndlovu
- Nontobeko MokoneNMNontobeko Mokone
- Baraka OnjareBOBaraka Onjare
- Andrew MgangaAMAndrew Mganga
- Kristian van KalmthoutKKKristian van Kalmthout
- Degu JereneDJDegu Jerene
Open Access
- 6 March 2025
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (3) , 68
Abstract
Digital adherence technologies (DATs) could improve the person-centeredness of tuberculosis (TB) treatment. DATs are found to be acceptable, though evidence of their effectiveness is varied. Our objective was to understand the fidelity of DAT interventions within five cluster-randomized trials. Two DATs (smart pillbox, medication labels) were assessed, with real-time adherence data available to healthcare providers (HCPs) on a digital platform in Ethiopia, the Philippines, South Africa, Tanzania, and Ukraine. A framework assessed four components of implementation: inputs (training, support, mobile access), processes (SMS, home visits, platform usage), outputs (DAT engagement, manual dosing), and outcomes (people with TB (PwTB)–HCP relationship). Fidelity was evaluated by quantitative indicators, and content analysis of qualitative sub-studies supplemented some indicators. Engagement with DATs was high among PwTB. Pillbox users showed high levels of sustained engagement (box opening), with digitally recorded doses ranging from 82% to 91%. Differences were observed in login frequency by HCPs to the adherence platform. In Ethiopia, Tanzania, and Ukraine, there was at least one login to the platform on 71% of weekdays per facility compared with the Philippines and South Africa at 42% and 52%, respectively. Intervention fidelity varied among countries, suggesting a need for future work on optimizing implementation.Keywords
All Related Versions
Funding Information
- Unitaid (2019–33-ASCENT)
This publication has 35 references indexed in Scilit:
- Contextual factors influencing implementation of tuberculosis digital adherence technologies: a scoping review guided by the RE-AIM frameworkBMJ Global Health, 2025
- Implementation outcomes of tuberculosis digital adherence technologies: a scoping review using the RE-AIM frameworkBMJ Global Health, 2025
- The performance of digital technologies for measuring tuberculosis medication adherence: a systematic reviewBMJ Global Health, 2024
- Cluster-randomized trial of digital adherence technologies and differentiated care to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive pulmonary TB in EthiopiamedRxiv, 2024
- The Impact of Digital Adherence Technologies on Health Outcomes in Tuberculosis: A Systematic Review and Meta-AnalysismedRxiv, 2024
- Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trialThe Lancet Global Health, 2023
- Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trialeClinicalMedicine, 2023
- The PRECIS-2 tool: designing trials that are fit for purposeBMJ, 2015
- Process evaluation of complex interventions: Medical Research Council guidanceBMJ, 2015
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008